|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0013470,
umls-concept:C0028754,
umls-concept:C0036239,
umls-concept:C0332307,
umls-concept:C0537551,
umls-concept:C0681850,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-5-13
|
|
pubmed:abstractText |
Long-term trials in insulin-treated subjects with type 2 diabetes have shown that adjunctive treatment with the amylin analogue pramlintide reduces HbA(1)c levels and elicits weight loss. While amylin reduces food intake in rodents, pramlintide's effect on satiety and food intake in humans has not yet been assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0012-186X
|
|
pubmed:author |
pubmed-author:BurnsCC,
pubmed-author:ChapmanII,
pubmed-author:DoraiHH,
pubmed-author:Feinle-BissetCC,
pubmed-author:HorowitzMM,
pubmed-author:LushCC,
pubmed-author:ParkerBB,
pubmed-author:StrobelSS,
pubmed-author:WangYY,
pubmed-author:WeyerCC,
pubmed-author:WishartJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
838-48
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15843914-Adult,
pubmed-meshheading:15843914-Amyloid,
pubmed-meshheading:15843914-Body Mass Index,
pubmed-meshheading:15843914-Diabetes Complications,
pubmed-meshheading:15843914-Diabetes Mellitus, Type 2,
pubmed-meshheading:15843914-Double-Blind Method,
pubmed-meshheading:15843914-Energy Intake,
pubmed-meshheading:15843914-Energy Metabolism,
pubmed-meshheading:15843914-Female,
pubmed-meshheading:15843914-Humans,
pubmed-meshheading:15843914-Hunger,
pubmed-meshheading:15843914-Hypoglycemic Agents,
pubmed-meshheading:15843914-Islet Amyloid Polypeptide,
pubmed-meshheading:15843914-Male,
pubmed-meshheading:15843914-Middle Aged,
pubmed-meshheading:15843914-Obesity,
pubmed-meshheading:15843914-Placebos,
pubmed-meshheading:15843914-Satiation
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
|
|
pubmed:affiliation |
Department of Medicine, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
